115 related articles for article (PubMed ID: 2139189)
21. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
22. Anticonvulsant action of SCH 23390 in the striatum of the rat.
al-Tajir G; Starr MS
Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
[TBL] [Abstract][Full Text] [Related]
23. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
24. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors.
Alam AM; Starr MS
Eur J Pharmacol; 1992 Nov; 222(2-3):227-32. PubMed ID: 1451735
[TBL] [Abstract][Full Text] [Related]
25. Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes.
Saller CF; Kreamer LD
Brain Res; 1991 Apr; 546(2):235-40. PubMed ID: 1829974
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
Palacios JM; Wiederhold KH
Brain Res; 1985 Feb; 327(1-2):390-4. PubMed ID: 3157422
[TBL] [Abstract][Full Text] [Related]
27. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
28. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
29. Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance.
Levin ED; Rose JE
Pharmacol Biochem Behav; 1991 Feb; 38(2):243-6. PubMed ID: 1676165
[TBL] [Abstract][Full Text] [Related]
30. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
[TBL] [Abstract][Full Text] [Related]
31. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
Faunt JE; Crocker AD
Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
[TBL] [Abstract][Full Text] [Related]
32. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
White FJ; Hu XT; Brooderson RJ
Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
[No Abstract] [Full Text] [Related]
33. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
34. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
Delfs JM; Kelley AE
Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor subtypes and formalin test analgesia.
Morgan MJ; Franklin KB
Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
[TBL] [Abstract][Full Text] [Related]
36. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
Arnt J; Hyttel J; Perregaard J
Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
[TBL] [Abstract][Full Text] [Related]
37. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
38. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
Puglisi-Allegra S; Cabib S
Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
[TBL] [Abstract][Full Text] [Related]
39. Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
Asin KE; Montana WE
Pharmacol Biochem Behav; 1989 Apr; 32(4):1033-41. PubMed ID: 2572001
[TBL] [Abstract][Full Text] [Related]
40. Dopaminergic regulation of epileptic activity.
Barone P; Palma V; de Bartolomeis A; Cicarelli G; Campanella G
Neurochem Int; 1992 Mar; 20 Suppl():245S-249S. PubMed ID: 1365435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
